UPDATE 1-Roche to buy U.S. biotech firm InterMune for $8.3 bln
August 24, 2014 at 13:06 PM EDT
* Roche sees transaction neutral for core EPS in 2015 (Adds further comment from Roche, background)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.